Physician profile
John Ryan Logan
NPI 1801059381
$1,365.24
in general payments reported to CMS, 2019-2025
19 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.08 · 2020: $106 · 2021: $248 · 2022: $277 · 2023: $61.48 · 2024: $379 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $355.94 | 2020-2025 | |
| Lexicon Pharmaceuticals, INC. | $158.56 | 2024 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $129.94 | 2019-2025 | Eliquis, Camzyos |
| Abbvie INC. | $107.60 | 2023-2025 | |
| Vifor Pharma, INC. | $96.81 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $61.51 | 2019-2022 | |
| Boston Scientific Corporation | $56.86 | 2025 | Watchman Access System |
| Melinta Therapeutics, LLC | $55.01 | 2022-2024 | Rezzayo, Kimyrsa |
| Janssen Pharmaceuticals, INC | $52.93 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $49.80 | 2019-2021 | |
| Mylan Specialty L.P. | $46.51 | 2019-2024 | Yupelri |
| Allergan, INC. | $39.18 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $35.64 | 2024 | Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $29.41 | 2024 | Arcalyst |
| Mallinckrodt Hospital Products INC. | $23.14 | 2024 | Terlivaz |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.01 | 2022 | |
| Csl Behring | $18.25 | 2020 | |
| Gilead Sciences, INC. | $14.62 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Logan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.